Publications by authors named "Karl Vass"

Claim this Profile
V
Veins in plaques of multiple sclerosis patients - a longitudinal magnetic resonance imaging study at 7 Tesla.
Assunta Dal-Bianco, Simon Hametner, Günther Grabner, Melanie Schernthaner, Claudia Kronnerwetter, Clemens Vass, Karl Vass

Eur Radiol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.
Fahmy Aboul-Enein, Thomas Seifert-Held, Simone Mader, Bettina Kuenz, Andreas Lutterotti, Karl Vass

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis.
Sabine Salhofer-Polanyi, Judith Windt, Harald Sumper, Hermine Grill, Maria Essmeister, Karl Vass

NeuroRehabilitation· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Franz Fazekas, Ovidiu Bajenaru, Thomas Berger, Tanja Hojs Fabjan, Alenka Horvat Ledinek, Karl Vass

Front Neurol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natalizumab therapy for highly active pediatric multiple sclerosis.
Barbara Kornek, Fahmy Aboul-Enein, Kevin Rostasy, Ruxandra-Iulia Milos, Irene Steiner, Karl Vass

JAMA Neurol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current immune therapies of autoimmune disease of the nervous system with special emphasis to multiple sclerosis.
Karl Vass

Curr Pharm Des· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
Barbara Kornek, Beate Schmitl, Karl Vass, Sonja Zehetmayer, Martin Pritsch

Mult Scler· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Franz Fazekas, Thomas Berger, Tanja Hojs Fabjan, Alenka Horvat Ledinek, Gábor Jakab, Karl Vass

Wien Med Wochenschr· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.
Mascha C Schmied, Sonja Zehetmayer, Markus Reindl, Rainer Ehling, Barbara Bajer-Kornek, Karl Vass

Neurogenetics· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.
Ludwig Kappos, David Bates, Gilles Edan, Mefkûre Eraksoy, Antonio Garcia-Merino, Karl Vass

Lancet Neurol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.
João Carlos Correia de Sa, Laura Airas, Emmanuel Bartholome, Nikolaos Grigoriadis, Heinrich Mattle, Karl Vass

Ther Adv Neurol Disord· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI.
Günther Grabner, Assunta Dal-Bianco, Melanie Schernthaner, Karl Vass, Hans Lassmann

J Magn Reson Imaging· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and quality of life of multiple sclerosis in Austria.
Gisela Kobelt, Jenny Berg, Peter Lindgren, Carlotta Plesnilla, Ulf Baumhackl, Karl Vass

Eur J Health Econ· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis